**Question:** Estrogen administration in a menopausal woman increases the

A. Estrogen Receptors
B. Follicle Stimulating Hormone (FSH) levels
C. Luteinizing Hormone (LH) levels
D. Progesterone production

**Core Concept:**

Estrogen is a hormone that plays a significant role in maintaining the female reproductive system and overall health in women. It exerts its effects through estrogen receptors, which are proteins that bind to estrogen and initiate a cascade of physiological responses. In postmenopausal women, estrogen deficiency leads to various symptoms and complications, including osteoporosis, cardiovascular disease, and cognitive decline. Estrogen replacement therapy is often prescribed to alleviate these symptoms and improve overall health.

**Why the Correct Answer is Right:**

Estrogen administration in a menopausal woman increases the number and sensitivity of estrogen receptors. This is because estrogen is being replaced, which helps to maintain the normal physiological response to estrogen. By increasing receptor number and sensitivity, estrogen replacement therapy can modulate various physiological processes, such as bone remodeling, cardiovascular system function, and cognitive performance, thus alleviating the symptoms associated with menopause.

**Why Each Wrong Option is Incorrect:**

A. Estrogen receptors are the correct answer because they are the molecular targets of estrogen action. Increasing these receptors improves the effectiveness of estrogen replacement therapy.

B. FSH levels are not directly influenced by estrogen administration in menopausal women. FSH is a gonadotropin hormone produced by the anterior pituitary gland that stimulates follicle development in the ovaries and is not directly affected by estrogen levels.

C. LH levels are also not directly influenced by estrogen administration in menopausal women. LH is another gonadotropin hormone produced by the anterior pituitary gland that stimulates the corpus luteum to produce progesterone, which is not directly affected by estrogen levels.

D. Progesterone is a hormone produced by the corpus luteum and not directly regulated by estrogen levels. Progesterone is influenced by luteinizing hormone (LH) and does not directly correlate with estrogen administration.

**Clinical Pearls and Memorandum:**

1. In postmenopausal women, estrogen replacement therapy is crucial for managing menopause-related symptoms, such as hot flushes, vaginal dryness, and mood changes.
2. Estrogen receptors are the primary targets for estrogen replacement therapy as increasing their number and sensitivity improves the effectiveness of estrogen treatment.
3. Monitoring FSH and LH levels is essential to evaluate the effectiveness of estrogen replacement therapy, but these hormones are not directly influenced by estrogen administration in menopausal women.
4. Progesterone is not a primary target of estrogen replacement therapy and is not directly influenced by estrogen levels in menopausal women.